Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 10 of 20
Students Education Training in Emotional Connection
NCT03680001
Imaging Inflammation in Alzheimer's Disease With 11C-ER176
NCT03744312
Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
NCT03220880
Prebiotic Fiber to Prevent Pathogen Colonization in the ICU
NCT03509753
Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial
NCT03462511
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
NCT03366012
Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study)
NCT03605693
Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation
NCT03511560
Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
NCT03817840
Neural Predictors of Social Emotion Regulation Training
NCT03487081
Increasing MSM in the Continuum of Care in Kazakhstan
NCT02786615
The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study
NCT03848650
Mitochondrial Stress, Brain Imaging, and Epigenetics
NCT04831424
Imaging of Peri-operative (periOP) Lung Injury
NCT02978885
COPD Exacerbation Blood and Urine Biomarkers Study
NCT03823443
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
NCT03167606
Closed Incision Negative Pressure Therapy vs Standard of Care
NCT03061903
E-Support Groups in Multiple Sclerosis
NCT03574961
Improving Outcomes for Hemodialysis Patients
NCT03395366
Sleep Quality in High School Students With Asthma - II
NCT03329066
Bethanechol Prior to Pancreatic Surgery
NCT03572283
Implementing Hypertension Screening Guidelines in Primary Care
NCT03480217
Post-ICU Palliative Care Intervention (PIPCI) Trial
NCT03456323
Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery
NCT03233607
CBPR - BRCA Genetic Testing Among Orthodox Jews
NCT03624088
Treatment of Periodontitis With Er:YAG Laser
NCT03628872
Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine
NCT03778580
Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis
NCT03473665
Epacadostat and Pembrolizumab in Patients With GIST
NCT03291054
Anti-viral Therapy in Alzheimer's Disease
NCT03282916
PREPP: Preventing Postpartum Depression
NCT03283254
Upright Back Posture Device Study
NCT03769246
Body Composition and Adipose Tissue in HIV
NCT03226821
Personalizing Self-management in Diabetes - Pilot Study
NCT04757233
The Microenvironment in Barrett's Esophagus
NCT03060642
Primary Intensivists and Primary Nurses to Decrease Pediatric ICU Length of Stay
NCT03364933
Stamford Group Family Nurture Intervention
NCT03442439
The Wise App Trial for Improving Health Outcomes in PLWH
NCT03205982
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
NCT03396315
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
NCT03192215
Chronic Convection Enhanced Delivery of Topotecan
NCT03154996
Families-At-risk for Interstitial Lung Disease Study
NCT03641742
Predictors of Lorcaserin-Induced Weight Loss
NCT03353220
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease
NCT03321214
Orthosensor vs Conventional Total Knee Arthroplasty
NCT03628378
Decision Support for BRCA Testing in Ethnically Diverse Women
NCT03470402
MyHand: An Active Hand Orthosis for Stroke Patients
NCT03767894
Fitbit Activity Tracker to Predict Risk of Preterm Birth
NCT03304782
Family Nurture Intervention in the NICU at The Valley Hospital
NCT03267043
Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve
NCT03461705
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.